Literature DB >> 12196286

Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection.

Sharookh B Kapadia1, Beth Levine, Samuel H Speck, Herbert W Virgin.   

Abstract

Several gamma-herpesviruses encode homologs of host regulators of complement activation (RCA) proteins, suggesting that they have evolved immune evasion strategies targeting complement. We evaluated the role of complement factor C3 (C3) and the murine gamma-herpesvirus 68 (gammaHV68) RCA protein in viral pathogenesis. Deletion of the gammaHV68 RCA protein decreased virulence during acute CNS infection, and this attenuation was specifically reversed by deletion of host C3. The gammaHV68 RCA protein was also important for persistent viral replication and virulence in IFNgammaR(-/-) mice. In addition, C3 played a role in regulating latency, but this was not counteracted by the gammaHV68 RCA protein. We conclude that complement is a key host defense against gamma-herpesvirus infection and that gamma-herpesviruses have evolved an immune evasion strategy that is effective against complement-mediated antiviral responses during acute but not latent infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196286     DOI: 10.1016/s1074-7613(02)00369-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  40 in total

1.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency.

Authors:  Joy Loh; Dori A Thomas; Paula A Revell; Timothy J Ley; Herbert W Virgin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.

Authors:  Kyung Min Chung; M Kathryn Liszewski; Grant Nybakken; Alan E Davis; R Reid Townsend; Daved H Fremont; John P Atkinson; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

4.  Myelopeptide-5 is a novel endogenous immunoregulator recovering the functional activity of T-lymphocytes.

Authors:  R G Belevskaya; M V Kalyuzhnaya; L A Fonina; A A Mikhailova; R V Petrov
Journal:  Dokl Biol Sci       Date:  2007 Sep-Oct

Review 5.  Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence.

Authors:  Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

6.  Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Authors:  Sita Awasthi; John M Lubinski; Carolyn E Shaw; Shana M Barrett; Michael Cai; Fushan Wang; Michael Betts; Susan Kingsley; Daniel J Distefano; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 7.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 8.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

9.  In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.

Authors:  Laurent Gillet; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

10.  Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes.

Authors:  Linda Mark; O Brad Spiller; Marcin Okroj; Simon Chanas; Jim A Aitken; Scott W Wong; Blossom Damania; Anna M Blom; David J Blackbourn
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.